The FDA has partnered with Stanford University to streamline the way medical devices are designed, tested and evaluated through collaboration with the university's biodesign program, according to a Stanford news release.
Paul Yock, MD, director of Stanford's biodesign program, will spearhead the effort. The biodesign program provides medical technology training to teams of physicians, engineers and business students. In one year, the teams indentify a medical need, develop a device to fill that need, create a business plan and present their projects to venture capitalists. In its 11 years, the program has produced more than 200 patents and 24 start-up companies.
Related Articles on Medical Devices:
St. Jude Medical Wins $27M in Patent Infringement Decision Against Access Closure
Boston Scientific Release Video Response to Stent Deformation Claims
FDA Clears Medtronic's Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
Paul Yock, MD, director of Stanford's biodesign program, will spearhead the effort. The biodesign program provides medical technology training to teams of physicians, engineers and business students. In one year, the teams indentify a medical need, develop a device to fill that need, create a business plan and present their projects to venture capitalists. In its 11 years, the program has produced more than 200 patents and 24 start-up companies.
Related Articles on Medical Devices:
St. Jude Medical Wins $27M in Patent Infringement Decision Against Access Closure
Boston Scientific Release Video Response to Stent Deformation Claims
FDA Clears Medtronic's Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery